ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOKANDO CO.,LTD.
  3. Financials
  4. Earnings per share

KOKANDO CO.,LTD. (E00959)

Market cap
P/E ratio
Kokan-do manufactures over-the-counter medicines like cold and stomach remedies, blending Toyama's traditional medicine heritage with modern pharmaceutical operations.
SummaryFinancialsDividendsHistoryWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 20256.3-153.27%
Mar 31, 2024-11.8-92.15%
Mar 31, 2023-149.9+19.64%
Mar 31, 2022-125.3-8082.17%
Mar 31, 20211.6-91.98%
Mar 31, 202019.6-75.68%
Mar 31, 201980.5+60.72%
Mar 31, 201850.1-199.76%
Mar 31, 2017-50.2+418.80%
Mar 31, 2016-9.7-31.05%
Mar 31, 2015-14-199.43%
Mar 31, 201414.1-159.58%
Mar 31, 2013-23.7-62.62%
Mar 31, 2012-63.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat